Status:
UNKNOWN
Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Carcinogenesis
Oral Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
Study on the carcinogenesis of Gα12 in oral cancer, and chemopreventive possibility for the treatment of oral cancer using Ga12 inhibitor.
Detailed Description
To find out if there is prognostic value which to the performance of Gα12 of oral cancer in Taiwan and provide some reference for future treatment. We anticipate to enroll 40 persons with normal oral...
Eligibility Criteria
Inclusion
- Dysplasia or cancer of the oral cavity.
Exclusion
- pregnant woman
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT01919580
Start Date
December 1 2012
End Date
July 1 2014
Last Update
April 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital research Ethics Committee
Taipei, Taiwan, 10048